Prisons and health
Palliative care/compassionate release Terminally ill prisoners, if they have support from family or friends in the community, should be released on compassionate grounds so that they are able to die with dignity at home in the company of family or friends.
Quality assurance and monitoring of, and interventions for, HIV and hepatitis C and D Different measures should be implemented to optimize the result of the HIV programme. The development of guidance notes and standard operating procedures, based on national guidelines, strengthens the adherence of prison staff, both security and health, to the policy and strategy. All staff should be trained in these guides and the rationale and importance of their role in the response explained. Monitoring related to HIV should be aligned with and integrated into national HIV and other bloodborne diseases monitoring systems.
References 1. Policy brief. HIV prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions. Vienna, United Nations Office on Drugs and Crime, 2013 (http://www.unodc.org/ documents/hiv-aids/HIV_comprehensive_package_ prison_2013_eBook.pdf, accessed 16 November 2013). 2. Rapid advice: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva, World Health Organization, 2009 (http://www.who.int/hiv/pub/mtct/rapid_advice_mtct. pdf, accessed 16 November 2013). 3. Health care worker safety. Geneva, World Health Organization, 2003 (http://www.who.int/injection_ safety/toolbox/docs/AM_HCW_Safety.pdf, accessed 16 November 2013). 4. Post-exposure prophylaxis to prevent HIV infection: joint WHO/ILO guidelines on post-exposure prophylaxis (PEP) to prevent HIV infection. Geneva, World Health Organization and International Labour Organization, 2007 (http://whqlibdoc.who.int/ publications/2007/9789241596374_eng.pdf, accessed 16 November 2013). 5. Wiersma ST et al. Treatment of chronic hepatitis B virus infection in resource constrained settings: expert panel consensus. Liver International, 2011, 31(6):755– 765. 6. Interpretation of hepatitis B serologic test results [web site]. Atlanta, GA, Centers for Disease Control and Prevention, 2013 (http://www.cdc.gov/hepatitis/HBV/ PDFs/SerologicChartv8.pdf, accessed 16 November 2013). 7. HIV/AIDS. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection 54
[web site]. Geneva, World Health Organization, 2013 (http://www.who.int/entity/hiv/pub/guidelines/arv2013/ download/en/index.html, accessed 16 November 2013). 8. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, World Health Organization, 2007 (http://www. who.int/hiv/pub/guidelines/HIVstaging150307.pdf, accessed 16 November 2013). 9. Effectiveness of interventions to address HIV in prisons. HIV care, treatment and support. Geneva, World Health Organization, 2007 (Evidence for Action Technical Paper) (http://www.who.int/hiv/pub/prisons/e4a_prisons/en/ index.html, accessed 16 November 2013). 10. HIV/AIDS, Antiretroviral therapy [web site]. Geneva, World Health Organization, 2013 (http://www.who. int/hiv/topics/treatment/en/index.html, accessed 16 November 2013). 11. WHO Expert Consultation on Cotrimoxazole Prophylaxis in HIV Infection. Report of a WHO Expert Consultation, Geneva, 10–12 May 2005. Geneva, World Health Organization, 2006 (WHO Technical Report Series) (http://www.who.int/hiv/pub/meetingreports/ctxprop hylaxismeeting.pdf, accessed 16 November 2013). 12. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, World Health Organization, 2011 (http://whqlibdoc. who.int/publications/2011/9789241500708_eng.pdf, accessed 16 November 2013). 13. EASL clinical practice guidelines: management of chronic hepatitis B. Journal of Hepatology, 2009, 50:227–242 (http://www.easl.eu/assets/application/ files/b73c0da3c52fa1d_file.pdf, accessed 16 November 2013). 14. EASL clinical practice guidelines: management of hepatitis C virus infection. Journal of Hepatology, 2011, 55:245–264 (http://www.easl.eu/assets/application/ files/4a7bd873f9cccbf_file.pdf, accessed 16 November 2013). Further reading HIV/AIDS prevention, care, treatment, and support in prison settings: a framework for an effective national response. Vienna, United Nations Office on Drugs and Crime, 2006 (http://www.unodc.org/pdf/HIV-AIDS_ prisons_July06.pdf, accessed 16 November 2013). This document provides a framework for mounting an effective national response to HIV in prisons, based on the evidence reviewed in the Evidence for Action Technical Paper and on accepted international standards and guidelines. HIV and AIDS in places of detention. A toolkit for policymakers, programme managers, prison officers and